Profit on $475,000 Novartis Cancer Drug Could Be a While Coming Profit on $475,000 Novartis Cancer Drug Could Be a While Coming

Novartis ' s new gene-modifying cancer therapy ' s $475,000-per-patient sticker price has drawn fire from advocate groups calling for cheaper drugs, but analysts said the Swiss drugmaker could initially struggle to break even.Reuters Health Information
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Medscape Today News Source Type: news